Coronary artery stent releasing a drug composition for...

Details Coronary artery stent releasing a drug composition for... Coronary artery stent releasing a drug composition for...

A - Human Necessities

61

L

A61L 31/16 (2006.01) A61L 31/04 (2006.01) A61L 31/12 (2006.01)

Patent

CA 2636299

A stent is described that releases medicamentous composition to prevent and treat restenosis and the fabrication process that comprehends between 10,0 to 500,0 Ug/cm2 of the surface of the stent coated with rapamycin (sirolismus) or analogous and between 0,01 to 20,0 Ug/mm2 of the surface of the stent coated with paclitaxel or analogous.

L~invention concerne un stent qui libère une composition médicamenteuse pour prévenir et traiter une resténose, et un procédé de fabrication. 10,0 à 500,0 Ug/cm2 de la surface du stent sont enduits de rapamicyne (sirolimus) ou d~un analogue, et 0,01 à 20,0 Ug/mm2 de la surface du stent sont enduits de paclitaxel ou d~un analogue.

Affiliated with

Also associated with

Rating

Coronary artery stent releasing a drug composition for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Coronary artery stent releasing a drug composition for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Coronary artery stent releasing a drug composition for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2052325